1. A literature review of treatment-specific clinical prediction models in patients with breast cancer. (April 2020) Authors: Modi, Natansh D.; Sorich, Michael J.; Rowland, Andrew; Logan, Jessica M.; McKinnon, Ross A.; Kichenadasse, Ganessan; Wiese, Michael D.; Hopkins, Ashley M. Journal: Critical reviews in oncology/hematology Issue: Volume 148(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF‐targeted therapy: A pooled secondary analysis of clinical trials. Issue 9 (6th January 2016) Authors: Sorich, Michael J.; Kichenadasse, Ganessan; Rowland, Andrew; Woodman, Richard J.; Mangoni, Arduino A. Journal: International journal of cancer Issue: Volume 138:Issue 9(2016:May 01) Page Start: 2293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice. Issue 2 (3rd March 2016) Authors: Mangoni, Arduino A.; Woodman, Richard J.; Kichenadasse, Ganessan; Rowland, Andrew; Sorich, Michael J. Journal: Expert review of precision medicine and drug development Issue: Volume 1:Issue 2(2016) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?. Issue 1 (23rd September 2013) Authors: Shahnam, Adel; Roder, David M.; Tracey, Elizabeth A.; Neuhaus, Susan J.; Brown, Michael P.; Sorich, Michael J. Journal: Journal of evaluation in clinical practice Issue: Volume 20:Issue 1(2014) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis. (April 2021) Authors: Abuhelwa, Ahmad Y.; Foster, David J. R.; Manning-Bennett, Arkady; Sorich, Michael J.; Proudman, Susanna; Wiese, Michael D.; Hopkins, Ashley M. Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Determining the acceptable level of physician compliance with a treat‐to‐target strategy in early rheumatoid arthritis. (22nd December 2015) Authors: Wabe, Nasir; Sorich, Michael J.; Wechalekar, Mihir D.; Cleland, Leslie G.; McWilliams, Leah; Lee, Anita; Spargo, Llewellyn; Metcalf, Robert; Hall, Cindy; Proudman, Susanna M.; Wiese, Michael D. Journal: International journal of rheumatic diseases Issue: Volume 20:Number 5(2017) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of concomitant use of antihypertensives and immune check point inhibitors on cancer outcomes. Issue 7 (July 2021) Authors: Kichenadasse, Ganessan; Miners, John O.; Mangoni, Arduino A.; Rowland, Andrew; Sorich, Michael J.; Hopkins, Ashley M. Journal: Journal of hypertension Issue: Volume 39:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data. (28th February 2019) Authors: Hopkins, Ashley M.; Van Dyk, Madele; Rowland, Andrew; Sorich, Michael J. Journal: Pigment cell & melanoma research Issue: Volume 32:Number 4(2019) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of modafinil as a perpetrator of metabolic drug–drug interactions using a model informed cocktail reaction phenotyping trial protocol. (10th January 2018) Authors: Rowland, Angela; van Dyk, Madelé; Warncken, David; Mangoni, Arduino A.; Sorich, Michael J.; Rowland, Andrew Journal: British journal of clinical pharmacology Issue: Volume 84:Number 3(2018:Sep.) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides. Issue 1 (18th April 2021) Authors: Rodrigues, A. David; van Dyk, Madelé; Sorich, Michael J.; Fahmy, Alia; Useckaite, Zivile; Newman, Lauren A.; Kapetas, Asha J.; Mounzer, Reham; Wood, Linda S.; Johnson, Jillian G.; Rowland, Andrew Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 1(2021) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗